Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Elstein

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|October 7, 2011
Severe heart disease complicating pregnancy does not preclude a favourable pregnancy outcome: 15 years' experience in a single centreR Michaelson-Cohen, D Elstein, A Ioscovich, et al.
The European Respiratory Journal|February 1, 1996
Pulmonary function abnormalities in type I Gaucher diseaseE Kerem, D Elstein, A Abrahamov, et al.
The American Journal of Medicine|July 1, 1994
Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatmentA Zimran, D Elstein, R Kannai, et al.
British Journal of Haematology|December 12, 2001
High prevalence of low serum vitamin B12 in a multi-ethnic Israeli populationY Gielchinsky, D Elstein, R Green, et al.
Blood Cells, Molecules & Diseases|July 10, 2003
The 1226G (N370S) Gaucher mutation among patients with Legg-Calve-Perthes diseaseG Kenet, S Hayek, M Mor, et al.
Lancet (London, England)|June 10, 1995
Replacement therapy with imiglucerase for type 1 Gaucher's diseaseA Zimran, D Elstein, E Levy-Lahad, et al.
Lancet (London, England)|October 14, 1995
Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotypeA Abrahamov, D Elstein, V Gross-Tsur, et al.
The Journal of Pediatrics|April 1, 1995
Outcome of partial splenectomy for type I Gaucher diseaseA Zimran, D Elstein, R Schiffmann, et al.
Lancet (London, England)|May 9, 2000
Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesisT Cox, R Lachmann, C Hollak, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|January 6, 2001
[Relevance and feasibility of a surveillance system of the effects of atmospheric pollution]S Cassadou, L Pascal, H Prouvot, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|October 7, 2011
Severe heart disease complicating pregnancy does not preclude a favourable pregnancy outcome: 15 years' experience in a single centreR Michaelson-Cohen, D Elstein, A Ioscovich, et al.
The European Respiratory Journal|February 1, 1996
Pulmonary function abnormalities in type I Gaucher diseaseE Kerem, D Elstein, A Abrahamov, et al.
The American Journal of Medicine|July 1, 1994
Low-dose enzyme replacement therapy for Gaucher's disease: effects of age, sex, genotype, and clinical features on response to treatmentA Zimran, D Elstein, R Kannai, et al.
British Journal of Haematology|December 12, 2001
High prevalence of low serum vitamin B12 in a multi-ethnic Israeli populationY Gielchinsky, D Elstein, R Green, et al.
Blood Cells, Molecules & Diseases|July 10, 2003
The 1226G (N370S) Gaucher mutation among patients with Legg-Calve-Perthes diseaseG Kenet, S Hayek, M Mor, et al.
Lancet (London, England)|June 10, 1995
Replacement therapy with imiglucerase for type 1 Gaucher's diseaseA Zimran, D Elstein, E Levy-Lahad, et al.
Lancet (London, England)|October 14, 1995
Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotypeA Abrahamov, D Elstein, V Gross-Tsur, et al.
The Journal of Pediatrics|April 1, 1995
Outcome of partial splenectomy for type I Gaucher diseaseA Zimran, D Elstein, R Schiffmann, et al.
Lancet (London, England)|May 9, 2000
Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesisT Cox, R Lachmann, C Hollak, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|January 6, 2001
[Relevance and feasibility of a surveillance system of the effects of atmospheric pollution]S Cassadou, L Pascal, H Prouvot, et al.
Pageof 9